159 related articles for article (PubMed ID: 28211613)
1. Novel anticarcinoembryonic antigen antibody-drug conjugate has antitumor activity in the existence of soluble antigen.
Shinmi D; Nakano R; Mitamura K; Suzuki-Imaizumi M; Iwano J; Isoda Y; Enokizono J; Shiraishi Y; Arakawa E; Tomizuka K; Masuda K
Cancer Med; 2017 Apr; 6(4):798-808. PubMed ID: 28211613
[TBL] [Abstract][Full Text] [Related]
2. An anti-HER2 antibody conjugated with monomethyl auristatin E is highly effective in HER2-positive human gastric cancer.
Li H; Yu C; Jiang J; Huang C; Yao X; Xu Q; Yu F; Lou L; Fang J
Cancer Biol Ther; 2016 Apr; 17(4):346-54. PubMed ID: 26853765
[TBL] [Abstract][Full Text] [Related]
3. Impact of Different Selectivity between Soluble and Membrane-bound Forms of Carcinoembryonic Antigen (CEA) on the Target-mediated Disposition of Anti-CEA Monoclonal Antibodies.
Iwano J; Shinmi D; Masuda K; Murakami T; Enokizono J
Drug Metab Dispos; 2019 Nov; 47(11):1240-1246. PubMed ID: 31533926
[TBL] [Abstract][Full Text] [Related]
4. Humanisation and characterisation of PR1A3, a monoclonal antibody specific for cell-bound carcinoembryonic antigen.
Stewart LM; Young S; Watson G; Mather SJ; Bates PA; Band HA; Wilkinson RW; Ross EL; Snary D
Cancer Immunol Immunother; 1999 Feb; 47(6):299-306. PubMed ID: 10203059
[TBL] [Abstract][Full Text] [Related]
5. CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma.
Nakae R; Matsuzaki S; Serada S; Matsuo K; Shiomi M; Sato K; Nagase Y; Matsuzaki S; Nakagawa S; Hiramatsu K; Okazawa A; Kimura T; Egawa-Takata T; Kobayashi E; Ueda Y; Yoshino K; Naka T; Kimura T
Am J Obstet Gynecol; 2021 Feb; 224(2):197.e1-197.e23. PubMed ID: 32822640
[TBL] [Abstract][Full Text] [Related]
6. Targeted sonodynamic therapy of cancer using a photosensitizer conjugated with antibody against carcinoembryonic antigen.
Abe H; Kuroki M; Tachibana K; Li T; Awasthi A; Ueno A; Matsumoto H; Imakiire T; Yamauchi Y; Yamada H; Ariyoshi A; Kuroki M
Anticancer Res; 2002; 22(3):1575-80. PubMed ID: 12168839
[TBL] [Abstract][Full Text] [Related]
7. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody.
Stein R; Govindan SV; Hayes M; Griffiths GL; Hansen HJ; Horak ID; Goldenberg DM
Clin Cancer Res; 2005 Apr; 11(7):2727-34. PubMed ID: 15814655
[TBL] [Abstract][Full Text] [Related]
8. Development of ASG-15ME, a Novel Antibody-Drug Conjugate Targeting SLITRK6, a New Urothelial Cancer Biomarker.
Morrison K; Challita-Eid PM; Raitano A; An Z; Yang P; Abad JD; Liu W; Lortie DR; Snyder JT; Capo L; Verlinsky A; Aviña H; Doñate F; Joseph IB; Pereira DS; Morrison K; Stover DR
Mol Cancer Ther; 2016 Jun; 15(6):1301-10. PubMed ID: 26944921
[TBL] [Abstract][Full Text] [Related]
9. A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently.
Wang XB; Zhao BF; Zhao Q; Piao JH; Liu J; Lin Q; Huang HL
J Biochem; 2004 Apr; 135(4):555-65. PubMed ID: 15115782
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the antitumor effect on combination therapy of an anticancer drug and its antibody against carcinoembryonic antigen.
Shibaguchi H; Tsuru H; Kuroki M; Kuroki M
Chemotherapy; 2012; 58(2):110-7. PubMed ID: 22507917
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
[TBL] [Abstract][Full Text] [Related]
12. High antitumor activity of Sortase A-generated anti-CD20 antibody fragment drug conjugates.
Liu W; Zhao W; Bai X; Jin S; Li Y; Qiu C; Pan L; Ding D; Xu Y; Zhou Z; Chen S
Eur J Pharm Sci; 2019 Jun; 134():81-92. PubMed ID: 30986472
[TBL] [Abstract][Full Text] [Related]
13. CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.
Tse KF; Jeffers M; Pollack VA; McCabe DA; Shadish ML; Khramtsov NV; Hackett CS; Shenoy SG; Kuang B; Boldog FL; MacDougall JR; Rastelli L; Herrmann J; Gallo M; Gazit-Bornstein G; Senter PD; Meyer DL; Lichenstein HS; LaRochelle WJ
Clin Cancer Res; 2006 Feb; 12(4):1373-82. PubMed ID: 16489096
[TBL] [Abstract][Full Text] [Related]
14. A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors.
Bacac M; Fauti T; Sam J; Colombetti S; Weinzierl T; Ouaret D; Bodmer W; Lehmann S; Hofer T; Hosse RJ; Moessner E; Ast O; Bruenker P; Grau-Richards S; Schaller T; Seidl A; Gerdes C; Perro M; Nicolini V; Steinhoff N; Dudal S; Neumann S; von Hirschheydt T; Jaeger C; Saro J; Karanikas V; Klein C; Umaña P
Clin Cancer Res; 2016 Jul; 22(13):3286-97. PubMed ID: 26861458
[TBL] [Abstract][Full Text] [Related]
15. Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugates.
Law CL; Cerveny CG; Gordon KA; Klussman K; Mixan BJ; Chace DF; Meyer DL; Doronina SO; Siegall CB; Francisco JA; Senter PD; Wahl AF
Clin Cancer Res; 2004 Dec; 10(23):7842-51. PubMed ID: 15585616
[TBL] [Abstract][Full Text] [Related]
16. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy.
Shirasu N; Yamada H; Shibaguchi H; Kuroki M; Kuroki M
Int J Cancer; 2014 Dec; 135(11):2697-710. PubMed ID: 24740257
[TBL] [Abstract][Full Text] [Related]
17. A developed antibody-drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line.
Abdollahpour-Alitappeh M; Hashemi Karouei SM; Lotfinia M; Amanzadeh A; Habibi-Anbouhi M
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1-8. PubMed ID: 29523024
[TBL] [Abstract][Full Text] [Related]
18. A novel multifunctional anti-CEA-IL15 molecule displays potent antitumor activities.
Liu Y; Wang Y; Xing J; Li Y; Liu J; Wang Z
Drug Des Devel Ther; 2018; 12():2645-2654. PubMed ID: 30214153
[TBL] [Abstract][Full Text] [Related]
19. Immunological heterogeneity of carcinoembryonic antigen: antigenic determinants on carcinoembryonic antigen distinguished by monoclonal antibodies.
Primus FJ; Newell KD; Blue A; Goldenberg DM
Cancer Res; 1983 Feb; 43(2):686-92. PubMed ID: 6184152
[TBL] [Abstract][Full Text] [Related]
20. Combined radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with taxol.
Crow DM; Williams L; Colcher D; Wong JY; Raubitschek A; Shively JE
Bioconjug Chem; 2005; 16(5):1117-25. PubMed ID: 16173788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
